| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/28/2009 | CN101355970A Peptide-DICER substrate RNA conjugates as delivery vehicles for SIRNA |
| 01/28/2009 | CN101354397A Strategy for retroviral immunotherapy |
| 01/28/2009 | CN101353671A Preparation and use of recombinant virus vector gene A3G |
| 01/28/2009 | CN101353668A Mouse beta-alexin 1 recombinant plasmids, polypeptides, uses and preparations thereof |
| 01/28/2009 | CN101353378A Zone 2 protein of programmed cell death protein 2 analogue and uses thereof |
| 01/28/2009 | CN101353377A Zone 1 protein of programmed cell death protein 2 analogue and uses thereof |
| 01/28/2009 | CN101353375A Method for producing influenza hemagglutinin multivalent vaccine |
| 01/28/2009 | CN101353374A Pronucleus expressed hepatitis a virus recombinant antigen |
| 01/28/2009 | CN101353373A Synthetic peptide vaccines for foot-and-mouth disease |
| 01/28/2009 | CN101353351A Novel 2,3,3a,4-tetrahydro thiochromeno [4,3-c] pyrazole antiinflammatory antimycotic compound |
| 01/28/2009 | CN101353348A 7-[4-(aminomethyl)-4-fluoro-3-(alkoxyimine) pyrrolidine-1-yl] substituted quinoline carboxylic acid derivative and preparation thereof |
| 01/28/2009 | CN101353342A 2-pyridinyl-1H-benzimidazole-4-acidamide type derivative |
| 01/28/2009 | CN101353326A 2-hydroxy phenyl-1H-benzimidazole-4-acidamide type derivates |
| 01/28/2009 | CN101352571A Medicament for treating encephalitis b and preparation method thereof |
| 01/28/2009 | CN101352570A Diploid cell rabies vaccine and method for preparing purified rabies vaccine |
| 01/28/2009 | CN101352569A Diploid somatic cell encephalitis B vaccine and method for preparing purified encephalitis B vaccine |
| 01/28/2009 | CN101352534A Chinese medicinal composition, and preparation method and uses thereof |
| 01/28/2009 | CN101352521A Onychomycosis medicine and preparation method thereof |
| 01/28/2009 | CN101352500A Chinese medicine plaster for treating folliculitis keloidnlis nuchae |
| 01/28/2009 | CN101352496A Chinese medicine for treating hepatitis |
| 01/28/2009 | CN101352488A Medicament composition for damp-heat type icterohepatitis and preparation method thereof |
| 01/28/2009 | CN101352486A Isatis root and astragalus microspheres for injections and preparation method thereof |
| 01/28/2009 | CN101352484A Medicament composition for treating acute and chronic hepatitis |
| 01/28/2009 | CN101352464A Chinese medicinal composition and preparation method thereof and quality control method |
| 01/28/2009 | CN101352463A Plaster for treating parotiditis |
| 01/28/2009 | CN101352462A Chinese actinidia root triterpenes compounds and extracting method thereof |
| 01/28/2009 | CN101352451A Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
| 01/28/2009 | CN101352442A Sustained release tablets containing cefaclor active component and preparation method thereof |
| 01/28/2009 | CN101352424A Cefdinir dispersible tablet and preparation method thereof |
| 01/28/2009 | CN101352234A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 01/28/2009 | CN101352192A Ficus carica fruit tea and production method |
| 01/28/2009 | CN100455594C Polypeptide of controlling IIIv virus fusion and its use |
| 01/28/2009 | CN100455566C Novel derivatives of aminocyclohexane |
| 01/28/2009 | CN100455312C Traditional Chinese medicine for treating and preventing noxa of bee foulbrood, and its prepn. method |
| 01/28/2009 | CN100455290C Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 01/28/2009 | CN100455289C Anticancer compositions comprising methenamine |
| 01/28/2009 | CN100455283C Medicine containing acarnine compound as active component |
| 01/28/2009 | CN100455195C Synergistic microbicidal combination |
| 01/27/2009 | US7482454 Antimicrobial quinolones, their compositions, and uses |
| 01/27/2009 | US7482439 Caprazene as novel compound and derivatives thereof, and caprazol as novel compound and derivatives thereof |
| 01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482363 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 01/27/2009 | US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors |
| 01/27/2009 | US7482328 an artificially synthesized antimicrobial polypeptide that does not occur in nature contains in its peptide chain one or more types of nuclear localization signal sequences (NLSs); for drug resistance bacteria |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482137 glycosylation endproducts of polyketides, glycoproteins or polyketide-peptide substrates with microbial glycosyltransferases |
| 01/27/2009 | US7482115 Bacteriophage; antibiotics or bacteriostatic agents for treatment of antibiotic-resistant infections; medical equipment |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482012 Streptococcus pyogenes polypeptides and corresponding DNA fragments |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | US7482000 Point mutations; immunology |
| 01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 01/27/2009 | CA2416403C A medicinal aerosol formulation |
| 01/27/2009 | CA2408941C New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives |
| 01/27/2009 | CA2389280C Triazoles as farnesyl transferase inhibitors |
| 01/27/2009 | CA2380757C Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 01/27/2009 | CA2309653C Use of protein h as cytostatic agent |
| 01/27/2009 | CA2294586C Homoserine lactones biofilm regulating compounds and their methods of use |
| 01/27/2009 | CA2290520C Inhibition of p38 kinase activity by aryl ureas |
| 01/27/2009 | CA2225278C Recombinant mva virus, and the use thereof |
| 01/27/2009 | CA2197319C Lipid analogs for treating viral infections |
| 01/27/2009 | CA2186747C Interleukin-15 |
| 01/27/2009 | CA2176298C A single high dose fluoroquinolone treatment |
| 01/25/2009 | CA2597865A1 Compositions for therapeutic treatment of hpv related conditions and diseases |
| 01/22/2009 | WO2009011941A2 Monoclonal antibodies against dengue and other viruses with deletion in fc region |
| 01/22/2009 | WO2009011912A1 A composition for treating hiv comprising virus-like particles |
| 01/22/2009 | WO2009011787A1 Anti-viral compounds, compositions, and methods of use |
| 01/22/2009 | WO2009011567A1 Crystalline forms of efavirenz |
| 01/22/2009 | WO2009011413A1 Production and use of epitope-tagged hepatitis c virus particle |
| 01/22/2009 | WO2009011276A1 Zinc salt of isothiazolone compound, method of reducing stimulus of isothiazolone compound, antibacterial/antifungal method employing zinc salt of isothiazolone compound, and antibacterial/antifungal composition |
| 01/22/2009 | WO2009010801A1 Spiro condensed barbituric acid derivatives for use as antibacterial |
| 01/22/2009 | WO2009010794A1 2,4-diamino-pyrimidine derivatives |
| 01/22/2009 | WO2009010785A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections |
| 01/22/2009 | WO2009010783A1 Macrocyclic indole derivatives for the treatment of hepatitis c infections |
| 01/22/2009 | WO2009010765A2 Lantibiotic-based compounds having antimicrobial activity |
| 01/22/2009 | WO2009010763A1 The use of type-b lantibiotic-based compounds having antimicrobial activity |
| 01/22/2009 | WO2009010479A2 Heterocyclic methylene piperidine derivatives and their use |
| 01/22/2009 | WO2009010477A1 Piperidine-4-acetic acid derivatives and their use |
| 01/22/2009 | WO2009010163A1 New antimicrobial compounds, their synthesis and their use for treatment of mammalian infections |
| 01/22/2009 | WO2009010021A1 Immunostimulatory activity of trilobolide and method of preparation thereof |
| 01/22/2009 | WO2009009951A1 2'-fluoro-4'-substituted nucleosides, the preparation and use |
| 01/22/2009 | WO2009009892A1 Engineered scfv against bovine herpes virus type i |
| 01/22/2009 | WO2009009876A1 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 01/22/2009 | WO2009009813A1 Organic compounds |
| 01/22/2009 | WO2008144590A3 Long lasting modified antifusogenic peptide for preventing hiv infection |
| 01/22/2009 | WO2008143500A4 Tenofovir disoproxil hemi-fumaric acid co-crystal |
| 01/22/2009 | WO2008116813A3 Combination medicaments for treating bacterial infections |
| 01/22/2009 | WO2008076447A3 Treatments of therapy-resistant diseases comprising drug combinations |
| 01/22/2009 | WO2008052737A3 Immunochemically equivalent hiv drug analogs |
| 01/22/2009 | WO2008026075A3 Treatment of intracellular bacterial infections with a protein kinase inhibitor or an as160 polypeptide activator |
| 01/22/2009 | US20090025098 Hepatitis C receptor protein CD81 |
| 01/22/2009 | US20090023813 1 1-(3-Chloro-5-trifluoromethyl-phenyl)-3-(4-chloro-3-trifluoromethyl-phenyl)-urea; sterilization, sanitation, antisepsis, disinfection, decolonisation or prevention of colonisation of the skin, gastro-intestinal tract or the nasal, ocular or dental area or any type of prosthetic device |
| 01/22/2009 | US20090023812 N,n-dihalogenated amino acids and derivatives |
| 01/22/2009 | US20090023804 Electrochemical methods for redox control to preserve, stabilize and activate compounds |
| 01/22/2009 | US20090023800 Cannabinoid receptor modulator |
| 01/22/2009 | US20090023796 Analogs of Indole-3-Carbinol Metabolites as Chemotherapeutic and Chemopreventive Agents |
| 01/22/2009 | US20090023795 Kinase Inhibitors And Methods Of Use Thereof |
| 01/22/2009 | US20090023764 administering pyrimidinedione compounds such as 1-cyclopropylmethyl-6-(3,5-dimethyl-phenylsulfanyl)-5-isopropyl-1H-pyrimidine-2,4-dione, exhibiting excellent inhibitory activity against hepatitis C virus infections |